# Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC

> **NCT06095167** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Fujian Cancer Hospital** · enrollment: 476 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** without concurrent cisplatin chemotherapy
- **DRUG:** with concurrent cisplatin chemotherapy

## Key facts

- **NCT ID:** NCT06095167
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 476 (ESTIMATED)
- **Last updated:** 2023-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06095167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06095167, "Induction Chemotherapy and Immunotherapy Combined Radiotherapy With or Without Concurrent Chemotherapy for Stage III-IVa NPC". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06095167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*